193 related articles for article (PubMed ID: 10037481)
21. Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.
Reith ME; Xu C; Zhang L; Coffey LL
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):295-304. PubMed ID: 8878059
[TBL] [Abstract][Full Text] [Related]
22. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
[TBL] [Abstract][Full Text] [Related]
23. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
[TBL] [Abstract][Full Text] [Related]
25. Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects.
Katz JL; Izenwasser S; Terry P
Psychopharmacology (Berl); 2000 Jan; 148(1):90-8. PubMed ID: 10663422
[TBL] [Abstract][Full Text] [Related]
26. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
Wall SC; Innis RB; Rudnick G
Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
[TBL] [Abstract][Full Text] [Related]
27. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
Staley JK; Hearn WL; Ruttenber AJ; Wetli CV; Mash DC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1678-85. PubMed ID: 7996484
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for substrate recognition by the human dopamine transporter.
Appell M; Berfield JL; Wang LC; Dunn WJ; Chen N; Reith ME
Biochem Pharmacol; 2004 Jan; 67(2):293-302. PubMed ID: 14698042
[TBL] [Abstract][Full Text] [Related]
29. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
Valchar M; Hanbauer I
J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
Zhu J; Mactutus CF; Wallace DR; Booze RM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes.
Tidjane Corera A; Do-Régo JC; Costentin J; Bonnet JJ
Neurosci Res; 2001 Mar; 39(3):319-25. PubMed ID: 11248372
[TBL] [Abstract][Full Text] [Related]
32. Rat mesencephalic neuronal cells cultured for different periods as a model of dopamine transporter ontogenesis.
Valchár M; Hanbauer I
Mol Neurobiol; 1995; 11(1-3):111-9. PubMed ID: 8561956
[TBL] [Abstract][Full Text] [Related]
33. Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat.
Hebert MA; Larson GA; Zahniser NR; Gerhardt GA
J Pharmacol Exp Ther; 1999 Mar; 288(3):1334-9. PubMed ID: 10027875
[TBL] [Abstract][Full Text] [Related]
34. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
Houlihan WJ; Boja JW; Parrino VA; Kopajtic TA; Kuhar MJ
J Med Chem; 1996 Dec; 39(25):4935-41. PubMed ID: 8960553
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the functional activity of the human dopamine transporter by protein kinase C.
Zhang L; Coffey LL; Reith ME
Biochem Pharmacol; 1997 Mar; 53(5):677-88. PubMed ID: 9113087
[TBL] [Abstract][Full Text] [Related]
36. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
[TBL] [Abstract][Full Text] [Related]
37. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
Chen N; Trowbridge CG; Justice JB
J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
[TBL] [Abstract][Full Text] [Related]
38. Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species?
Berfield JL; Wang LC; Reith ME
J Biol Chem; 1999 Feb; 274(8):4876-82. PubMed ID: 9988729
[TBL] [Abstract][Full Text] [Related]
39. Cationic and anionic requirements for the binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane to the dopamine uptake carrier.
Reith ME; Coffey LL
J Neurochem; 1993 Jul; 61(1):167-77. PubMed ID: 8515263
[TBL] [Abstract][Full Text] [Related]
40. [3H]WIN 35,428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum.
Gracz LM; Madras BK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1224-34. PubMed ID: 7791095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
